8-K - Curanex Pharmaceuticals Inc Common Stock | StockGist

Current Report Details

Event Type

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On December

Management Change

$20.0KChief Financial Officer

9.01

. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Consulting Agreement dated December 31, 2025 between the Company and Wanjun Zhan

Exhibits Only

Exhibits (2)

10.1

EX-10.1

8-K